1	Pfizer	pfizer	NNP	_	3	poss	_
2	's	's	POS	_	1	possessive	_
3	efforts	effort	NNS	_	11	nsubj	11:A0=PAG
4	to	to	TO	_	5	aux	_
5	merge	merge	VB	pb=merge.01	3	infmod	_
6	with	with	IN	_	5	prep	5:A2=PPT
7	British	british	JJ	p2=NNP	9	amod	_
8	rival	rival	JJ	p2=NN	9	amod	_
9	AstraZeneca	astrazeneca	NNP	_	6	pobj	_
10	has	have	VBZ	_	11	aux	_
11	attracted	attract	VBN	pb=attract.01	0	root	_
12	significant	significant	JJ	_	14	amod	_
13	political	political	JJ	_	14	amod	_
14	opposition	opposition	NN	_	11	dobj	11:A1=PPT
15	.	.	.	_	11	punct	_

1	AstraZeneca	astrazeneca	NNP	_	3	poss	_
2	's	's	POS	_	1	possessive	_
3	board	board	NN	_	5	nsubj	5:A0=PAG
4	has	have	VBZ	_	5	aux	_
5	rejected	reject	VBN	pb=reject.01	0	root	_
6	yet	yet	RB	_	5	advmod	5:AM-TMP
7	another	another	DT	_	9	det	_
8	takeover	takeover	NN	_	9	nn	_
9	bid	bid	NN	p2=VBN	5	dobj	5:A1=PPT
10	from	from	IN	_	9	prep	_
11	Pfizer	pfizer	NNP	_	10	pobj	_
12	,	,	,	_	11	punct	_
13	a	a	DT	_	14	det	_
14	move	move	NN	_	11	appos	17:A0=PAG
15	that	that	WDT	_	17	nsubj	17:R-A0
16	could	could	MD	_	17	aux	17:AM-MOD
17	lead	lead	VB	pb=lead.03	14	rcmod	_
18	the	the	DT	_	20	det	_
19	U.S.	u.s.	NNP	_	20	nn	_
20	drugmaker	drugmaker	NN	p2=JJR	17	dobj	22:A0=PPT;17:A1=PPT
21	to	to	TO	_	22	aux	_
22	abandon	abandon	VB	pb=abandon.01	17	xcomp	17:A2=PRD
23	attempts	attempt	NNS	_	22	dobj	22:A1=DIR
24	to	to	TO	_	25	aux	_
25	complete	complete	VB	pb=complete.01	23	infmod	_
26	a	a	DT	_	29	det	_
27	mega	mega	JJ	p2=NN	29	hmod	_
28	-	-	HYPH	_	29	hyph	_
29	merger	merger	NN	_	25	dobj	25:A1=PPT
30	with	with	IN	_	29	prep	_
31	its	its	PRP$	_	33	poss	_
32	British	british	JJ	_	33	amod	_
33	rival	rival	NN	_	30	pobj	_
34	.	.	.	_	5	punct	_

1	AstraZeneca	astrazeneca	NNP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	in	in	IN	_	2	prep	2:AM-LOC
4	a	a	DT	_	5	det	_
5	statement	statement	NN	_	3	pobj	_
6	that	that	IN	_	19	complm	_
7	Pfizer	pfizer	NNP	_	10	poss	_
8	's	's	POS	_	7	possessive	_
9	latest	late	JJS	_	10	amod	_
10	offer	offer	NN	_	19	nsubj	19:A0=PAG
11	of	of	IN	_	10	prep	_
12	£55.00	£0	NN	p2=CD	11	pobj	_
13	(	(	-LRB-	_	10	punct	_
14	$	$	$	_	15	nmod	_
15	95.52	0	CD	_	10	appos	_
16	)	)	-RRB-	_	10	punct	_
17	per	per	IN	_	10	prep	_
18	share	share	NN	_	17	pobj	_
19	undervalues	undervalue	VBZ	p2=IN|pb=undervalue.01	5	ccomp	_
20	the	the	DT	_	21	det	_
21	company	company	NN	_	19	dobj	19:A1=PPT
22	,	,	,	_	2	punct	_
23	and	and	CC	_	2	cc	_
24	constituted	constitute	VBD	pb=constitute.01	2	conj	_
25	only	only	RB	_	28	advmod	_
26	a	a	DT	_	28	det	_
27	minor	minor	JJ	_	28	amod	_
28	improvement	improvement	NN	_	24	dobj	24:A1=PPT
29	over	over	IN	_	28	prep	_
30	the	the	DT	_	31	det	_
31	company	company	NN	_	34	poss	_
32	's	's	POS	_	31	possessive	_
33	previous	previous	JJ	_	34	amod	_
34	offer	offer	NN	_	29	pobj	_
35	.	.	.	_	2	punct	_

1	Pfizer	pfizer	NNP	p2=NN	5	nsubj	5:A0
2	(	(	-LRB-	_	1	punct	_
3	PFE	pfe	NNP	_	1	appos	_
4	)	)	-RRB-	_	1	punct	_
5	said	say	VBD	pb=say.01	0	root	_
6	late	late	JJ	p2=RB	7	amod	_
7	Sunday	sunday	NNP	_	5	npadvmod	5:AM-TMP
8	that	that	IN	_	13	complm	_
9	the	the	DT	_	11	det	_
10	new	new	JJ	_	11	amod	_
11	bid	bid	NN	_	13	nsubj	13:A1=PPT
12	would	would	MD	_	13	aux	13:AM-MOD
13	be	be	VB	pb=be.01	5	ccomp	5:A1=PPT
14	its	its	PRP$	_	18	poss	_
15	"	"	``	_	18	punct	_
16	final	final	JJ	_	18	amod	_
17	"	"	''	_	18	punct	_
18	overture	overture	NN	p2=JJ	13	attr	13:A2=PRD
19	,	,	,	_	13	punct	_
20	and	and	CC	_	13	cc	_
21	that	that	IN	_	25	mark	_
22	it	it	PRP	_	25	nsubj	25:A0=PAG
23	would	would	MD	_	25	aux	25:AM-MOD
24	not	not	RB	_	25	neg	25:AM-NEG
25	make	make	VB	pb=make.05	13	conj	_
26	a	a	DT	_	28	det	_
27	hostile	hostile	JJ	_	28	amod	_
28	bid	bid	NN	_	25	dobj	25:AM-PRR
29	for	for	IN	_	28	prep	_
30	AstraZeneca	astrazeneca	NNP	_	29	pobj	_
31	(	(	-LRB-	_	30	punct	_
32	AZN	azn	NNP	_	30	appos	_
33	)	)	-RRB-	_	30	punct	_
34	.	.	.	_	5	punct	_

1	The	the	DT	_	2	det	_
2	offer	offer	NN	p2=VBP	3	nsubj	3:A0;12:A1=PPT
3	valued	value	VBD	p2=VBN|pb=value.01	0	root	_
4	AstraZeneca	astrazeneca	NNP	_	3	dobj	3:A1
5	at	at	IN	_	3	prep	3:A2=PRD
6	nearly	nearly	RB	_	9	advmod	_
7	$	$	$	_	9	quantmod	_
8	120	0	CD	_	9	number	_
9	billion	#crd#	CD	_	5	pobj	_
10	,	,	,	_	3	punct	_
11	and	and	CC	_	3	cc	_
12	was	be	VBD	pb=be.01	3	conj	_
13	a	a	DT	_	16	det	_
14	45	0	CD	_	15	num	_
15	%	%	NN	_	16	nn	_
16	premium	premium	NN	_	12	attr	12:A2=PRD
17	over	over	IN	_	16	prep	_
18	the	the	DT	_	19	det	_
19	company	company	NN	_	22	poss	_
20	's	's	POS	_	19	possessive	_
21	share	share	NN	_	22	nn	_
22	price	price	NN	_	17	pobj	_
23	in	in	IN	_	22	prep	_
24	mid-April	mid-april	NNP	p2=NN	23	pobj	_
25	.	.	.	_	3	punct	_

1	Shares	share	NNS	_	6	nsubj	6:A1=PPT;11:A1
2	in	in	IN	_	1	prep	_
3	the	the	DT	_	5	det	_
4	British	british	JJ	_	5	amod	_
5	company	company	NN	_	2	pobj	_
6	plunged	plunge	VBD	pb=plunge.01	0	root	_
7	nearly	nearly	RB	_	8	advmod	_
8	14	0	CD	_	9	num	_
9	%	%	NN	_	6	npadvmod	6:A2=EXT
10	to	to	TO	p2=IN	11	aux	_
11	£41.57	£0	VB	p2=CD|pb=£0.01	6	advcl	6:AM-PRP
12	in	in	IN	_	11	prep	11:AM-LOC
13	early	early	JJ	_	14	amod	_
14	trading	trading	NN	_	12	pobj	_
15	Monday	monday	NNP	_	11	npadvmod	11:AM-TMP
16	.	.	.	_	6	punct	_

1	AstraZeneca	astrazeneca	NNP	_	4	nsubj	4:A0=PAG
2	has	have	VBZ	_	4	aux	_
3	now	now	RB	_	4	advmod	4:AM-TMP
4	rejected	reject	VBN	pb=reject.01	0	root	_
5	four	#crd#	CD	_	6	num	_
6	proposals	proposal	NNS	_	4	dobj	4:A1=PPT
7	from	from	IN	_	6	prep	_
8	Pfizer	pfizer	NNP	_	7	pobj	_
9	.	.	.	_	4	punct	_

1	The	the	DT	_	2	det	_
2	company	company	NN	_	4	poss	_
3	's	's	POS	_	2	possessive	_
4	board	board	NN	_	5	nsubj	5:A0
5	said	say	VBD	pb=say.01	0	root	_
6	Monday	monday	NNP	_	5	npadvmod	5:AM-TMP
7	it	it	PRP	_	9	nsubjpass	9:A1=PPT
8	was	be	VBD	_	9	auxpass	_
9	convinced	convince	VBN	pb=convince.01	5	ccomp	5:A1=PPT
10	that	that	IN	_	16	complm	_
11	Pfizer	pfizer	NNP	_	14	poss	_
12	's	's	POS	_	11	possessive	_
13	takeover	takeover	NN	_	14	nn	_
14	hopes	hope	NNS	p2=VBZ	16	nsubjpass	16:A1=PPT
15	were	be	VBD	_	16	auxpass	_
16	driven	drive	VBN	pb=drive.02	9	ccomp	9:A2=PRD
17	by	by	IN	_	16	agent	16:A0=PAG
18	potential	potential	JJ	_	23	amod	_
19	cost	cost	NN	_	20	nn	_
20	savings	saving	NNS	_	23	nn	_
21	and	and	CC	_	20	cc	_
22	tax	tax	NN	_	23	nn	_
23	minimization	minimization	NN	_	17	pobj	_
24	.	.	.	_	5	punct	_

1	"	"	``	p2=''	40	punct	_
2	From	from	IN	_	25	prep	25:AM-TMP
3	our	our	PRP$	_	5	poss	_
4	first	#ord#	JJ	_	5	amod	_
5	meeting	meeting	NN	_	2	pobj	_
6	in	in	IN	_	5	prep	_
7	January	january	NNP	_	6	pobj	_
8	to	to	IN	_	2	prep	_
9	our	our	PRP$	_	11	poss	_
10	latest	late	JJS	_	11	amod	_
11	discussion	discussion	NN	_	8	pobj	_
12	yesterday	yesterday	NN	_	2	npadvmod	_
13	,	,	,	_	2	punct	_
14	and	and	CC	_	2	cc	_
15	in	in	IN	_	25	prep	25:AM-LOC
16	the	the	DT	_	19	det	_
17	numerous	numerous	JJ	_	19	amod	_
18	phone	phone	NN	_	19	nn	_
19	calls	call	NNS	p2=VBZ	15	pobj	_
20	in	in	IN	p2=RP	19	prep	_
21	between	between	IN	p2=NN	19	prep	_
22	,	,	,	_	25	punct	_
23	Pfizer	pfizer	NNP	_	25	nsubj	27:A0=PAG;25:A1=PAG
24	has	have	VBZ	_	25	aux	_
25	failed	fail	VBN	pb=fail.01	40	ccomp	40:A1=PPT
26	to	to	TO	_	27	aux	_
27	make	make	VB	pb=make.02	25	xcomp	25:A2=PPT
28	a	a	DT	_	35	det	_
29	compelling	compelling	JJ	_	35	amod	_
30	strategic	strategic	JJ	_	35	amod	_
31	,	,	,	_	30	punct	_
32	business	business	NN	_	35	nn	_
33	or	or	CC	_	32	cc	_
34	value	value	NN	_	32	conj	_
35	case	case	NN	_	27	dobj	27:A1=PRD
36	,	,	,	_	40	punct	_
37	"	"	''	p2=``	40	punct	_
38	the	the	DT	_	39	det	_
39	board	board	NN	_	40	nsubj	40:A0
40	said	say	VBD	pb=say.01	0	root	_
41	.	.	.	_	40	punct	_

1	AstraZeneca	astrazeneca	NNP	_	3	poss	_
2	's	's	POS	_	1	possessive	_
3	board	board	NN	_	5	nsubj	5:A0
4	also	also	RB	_	5	advmod	5:AM-ADV
5	revealed	reveal	VBD	pb=reveal.01	0	root	_
6	that	that	IN	_	10	complm	_
7	it	it	PRP	_	10	nsubj	10:A0=PAG
8	would	would	MD	_	10	aux	10:AM-MOD
9	only	only	RB	_	10	advmod	10:AM-ADV
10	consider	consider	VB	pb=consider.02	5	ccomp	5:A1=PPT
11	bids	bid	NNS	_	10	dobj	10:A1=PPT;13:A1=PPT
12	that	that	WDT	_	13	nsubj	13:R-A1
13	were	be	VBD	pb=be.01	11	rcmod	_
14	worth	worth	JJ	_	13	acomp	13:A2=PRD
15	at	at	IN	p2=RB	16	advmod	_
16	least	least	JJS	p2=RBS	17	advmod	_
17	£58.85	£0	CD	p2=NNS	14	npadvmod	_
18	.	.	.	_	5	punct	_

1	Since	since	IN	_	4	mark	_
2	Pfizer	pfizer	NNP	_	4	nsubj	4:A0=PAG
3	has	have	VBZ	_	4	aux	_
4	declared	declare	VBN	pb=declare.01	17	advcl	17:AM-CAU
5	the	the	DT	_	7	det	_
6	£55.00	£0	NN	p2=CD	7	nn	_
7	bid	bid	NN	p2=VBN	4	dobj	4:A1=PPT
8	to	to	TO	_	9	aux	_
9	be	be	VB	pb=be.01	7	infmod	_
10	its	its	PRP$	_	14	poss	_
11	"	"	``	_	14	punct	_
12	final	final	JJ	_	14	amod	_
13	"	"	''	_	14	punct	_
14	offer	offer	NN	p2=VBP	9	attr	9:A2=PRD
15	,	,	,	_	17	punct	_
16	it	it	PRP	_	17	nsubj	_
17	's	be	VBZ	pb=be.01	0	root	_
18	not	not	RB	_	17	neg	17:AM-NEG
19	clear	clear	JJ	_	17	acomp	17:A2=PRD
20	whether	whether	IN	_	24	complm	_
21	the	the	DT	_	22	det	_
22	companies	company	NNS	_	24	nsubj	27:A0=PAG;24:A1=PPT
23	will	will	MD	_	24	aux	24:AM-MOD
24	be	be	VB	pb=be.01	17	ccomp	17:A1=PPT
25	able	able	JJ	_	24	acomp	24:A2=PRD
26	to	to	TO	_	27	aux	_
27	close	close	VB	pb=close.01	25	xcomp	_
28	the	the	DT	_	29	det	_
29	gap	gap	NN	_	27	dobj	27:A1=PPT
30	.	.	.	_	17	punct	_

1	"	"	``	_	4	punct	_
2	We	we	PRP	_	4	nsubj	4:A0=PAG;7:A0=PAG;15:A0=PAG
3	have	have	VBP	_	4	aux	_
4	tried	try	VBN	pb=try.01	28	ccomp	28:A1=PPT
5	repeatedly	repeatedly	RB	_	4	advmod	4:AM-MNR
6	to	to	TO	_	7	aux	_
7	engage	engage	VB	pb=engage.01	4	xcomp	4:A1=PPT
8	in	in	IN	_	7	prep	7:A2=PPT
9	a	a	DT	_	11	det	_
10	constructive	constructive	JJ	_	11	amod	_
11	process	process	NN	_	8	pobj	_
12	with	with	IN	_	11	prep	_
13	AstraZeneca	astrazeneca	NNP	_	12	pobj	_
14	to	to	TO	_	15	aux	_
15	explore	explore	VB	pb=explore.01	7	advcl	7:AM-PRP
16	a	a	DT	_	17	det	_
17	combination	combination	NN	_	15	dobj	15:A1
18	of	of	IN	_	17	prep	_
19	our	our	PRP$	_	21	poss	_
20	two	#crd#	CD	_	21	num	_
21	companies	company	NNS	_	18	pobj	_
22	,	,	,	_	28	punct	_
23	"	"	''	p2=``	28	punct	_
24	Pfizer	pfizer	NNP	_	25	nn	_
25	CEO	ceo	NNP	_	27	nn	_
26	Ian	ian	NNP	_	27	nn	_
27	Read	read	NNP	_	28	nsubj	28:A0
28	said	say	VBD	pb=say.01	0	root	_
29	before	before	IN	p2=RB	31	mark	_
30	AstraZeneca	astrazeneca	NNP	_	31	nsubj	31:A0=PAG
31	rejected	reject	VBD	pb=reject.01	28	advcl	28:AM-TMP
32	the	the	DT	_	34	det	_
33	latest	late	JJS	_	34	amod	_
34	bid	bid	NN	_	31	dobj	31:A1=PPT
35	.	.	.	_	28	punct	_

1	The	the	DT	_	3	det	_
2	potential	potential	JJ	p2=NN	3	amod	_
3	takeover	takeover	NN	_	5	nsubj	5:A0=PAG
4	has	have	VBZ	_	5	aux	_
5	attracted	attract	VBN	pb=attract.01	0	root	_
6	significant	significant	JJ	_	8	amod	_
7	political	political	JJ	_	8	amod	_
8	attention	attention	NN	_	5	dobj	5:A1=PPT
9	,	,	,	_	5	punct	_
10	including	include	VBG	_	5	prep	_
11	calls	call	NNS	_	10	pobj	_
12	in	in	IN	_	11	prep	_
13	Britain	britain	NNP	_	12	pobj	_
14	for	for	IN	_	11	prep	_
15	new	new	JJ	_	16	amod	_
16	powers	power	NNS	_	14	pobj	19:A0=PAG
17	that	that	WDT	_	19	nsubj	19:R-A0
18	would	would	MD	_	19	aux	19:AM-MOD
19	allow	allow	VB	pb=allow.01	16	rcmod	_
20	the	the	DT	_	21	det	_
21	government	government	NN	_	23	nsubj	23:A0=PAG
22	to	to	TO	_	23	aux	_
23	prevent	prevent	VB	pb=prevent.01	19	ccomp	19:A1=PPT
24	takeovers	takeover	NNS	_	23	dobj	23:A1=PPT
25	by	by	IN	_	23	prep	23:A2=PPT
26	foreign	foreign	JJ	_	27	amod	_
27	firms	firm	NNS	_	25	pobj	_
28	in	in	IN	_	23	prep	_
29	the	the	DT	_	30	det	_
30	interest	interest	NN	_	28	pobj	_
31	of	of	IN	_	30	prep	_
32	national	national	JJ	_	33	amod	_
33	security	security	NN	_	31	pobj	_
34	.	.	.	_	5	punct	_

1	AstraZeneca	astrazeneca	NNP	_	3	amod	_
2	alone	alone	JJ	p2=RB	1	advmod	_
3	accounts	account	NNS	p2=VBZ	0	root	_
4	for	for	IN	_	3	prep	_
5	about	about	RB	p2=IN	6	advmod	_
6	2	0	CD	_	7	num	_
7	%	%	NN	_	4	pobj	_
8	of	of	IN	_	7	prep	_
9	British	british	JJ	_	10	amod	_
10	exports	export	NNS	_	8	pobj	_
11	,	,	,	_	3	punct	_
12	and	and	CC	_	3	cc	_
13	the	the	DT	_	14	det	_
14	deal	deal	NN	_	16	nsubj	16:A0=PAG
15	would	would	MD	_	16	aux	16:AM-MOD
16	represent	represent	VB	pb=represent.01	3	conj	_
17	the	the	DT	_	20	det	_
18	biggest	big	JJS	_	20	amod	_
19	foreign	foreign	JJ	_	20	amod	_
20	takeover	takeover	NN	_	16	dobj	16:A1=PPT
21	of	of	IN	_	20	prep	_
22	a	a	DT	_	24	det	_
23	British	british	JJ	_	24	amod	_
24	company	company	NN	_	21	pobj	_
25	.	.	.	_	16	punct	_

1	In	in	IN	_	17	prep	_
2	addition	addition	NN	_	1	pobj	_
3	to	to	IN	_	2	prep	_
4	an	an	DT	_	7	det	_
5	expanded	expand	VBN	pb=expand.01	7	amod	_
6	drug	drug	NN	_	7	nn	_
7	portfolio	portfolio	NN	_	3	pobj	5:A1=PPT
8	--	--	:	_	1	punct	_
9	particularly	particularly	RB	_	10	advmod	_
10	in	in	IN	_	3	prep	_
11	cancer	cancer	NN	_	12	nn	_
12	treatments	treatment	NNS	_	10	pobj	_
13	--	--	:	_	17	punct	_
14	a	a	DT	_	15	det	_
15	deal	deal	NN	_	17	nsubj	17:A0=PAG
16	would	would	MD	_	17	aux	17:AM-MOD
17	provide	provide	VB	pb=provide.01	0	root	_
18	a	a	DT	_	19	det	_
19	use	use	NN	_	17	dobj	17:A1=PPT
20	for	for	IN	_	19	prep	_
21	some	some	DT	_	20	pobj	_
22	of	of	IN	_	21	prep	_
23	the	the	DT	_	24	det	_
24	billions	#crd#	NNS	_	22	pobj	_
25	in	in	IN	p2=WDT	24	prep	_
26	profits	profit	NNS	_	25	pobj	_
27	Pfizer	pfizer	NNP	_	28	nsubj	28:A0=PAG
28	holds	hold	VBZ	pb=hold.01	24	rcmod	_
29	outside	outside	IN	p2=RB	28	prep	28:AM-LOC
30	the	the	DT	_	32	det	_
31	U.S.	u.s.	NNP	_	32	nn	_
32	Pfizer	pfizer	NNP	_	29	pobj	_
33	had	have	VBD	_	34	aux	_
34	amassed	amass	VBN	pb=amass.01	36	amod	_
35	financial	financial	JJ	_	36	amod	_
36	assets	asset	NNS	_	37	nn	34:A1=PPT
37	worth	worth	JJ	p2=IN	17	ccomp	_
38	nearly	nearly	RB	_	41	advmod	_
39	$	$	$	_	41	quantmod	_
40	50	0	CD	_	41	number	_
41	billion	#crd#	CD	_	37	npadvmod	_
42	at	at	IN	_	37	prep	_
43	the	the	DT	_	44	det	_
44	end	end	NN	_	42	pobj	_
45	of	of	IN	_	44	prep	_
46	2013	0	CD	_	45	pobj	_
47	,	,	,	_	37	punct	_
48	much	much	JJ	_	52	nsubjpass	52:A1;55:A1=PPT
49	of	of	IN	_	48	prep	_
50	which	which	WDT	_	49	pobj	_
51	is	be	VBZ	_	52	auxpass	_
52	reported	report	VBN	pb=report.01	37	conj	_
53	to	to	TO	_	55	aux	_
54	be	be	VB	_	55	auxpass	_
55	held	hold	VBN	pb=hold.04	52	xcomp	_
56	overseas	overseas	RB	_	55	advmod	55:AM-LOC
57	.	.	.	_	17	punct	_

1	Buying	buy	VBG	pb=buy.01	13	csubj	13:A0=PAG
2	AstraZeneca	astrazeneca	NNP	_	1	dobj	1:A1=PPT
3	and	and	CC	_	1	cc	_
4	basing	base	VBG	pb=base.02	1	conj	_
5	the	the	DT	_	8	det	_
6	new	new	JJ	_	8	amod	_
7	combined	combine	VBN	p2=JJ|pb=combine.01	8	amod	_
8	group	group	NN	_	4	dobj	4:A1=PPT;7:A1=PPT
9	in	in	IN	_	4	prep	4:AM-LOC
10	the	the	DT	_	11	det	_
11	U.K.	u.k.	NNP	_	9	pobj	_
12	would	would	MD	_	13	aux	13:AM-MOD
13	allow	allow	VB	pb=allow.01	0	root	_
14	it	it	PRP	_	16	nsubj	16:A0=PAG
15	to	to	TO	_	16	aux	_
16	make	make	VB	pb=make.02	13	ccomp	13:A1=PPT
17	use	use	NN	_	16	dobj	16:AM-PRR
18	of	of	IN	_	17	prep	_
19	those	those	DT	_	20	det	_
20	funds	fund	NNS	_	18	pobj	_
21	--	--	:	_	16	punct	_
22	for	for	IN	_	16	prep	_
23	M&A	m&a	NNP	_	22	pobj	_
24	,	,	,	_	23	punct	_
25	buybacks	buyback	NNS	p2=UH	23	conj	_
26	,	,	,	_	25	punct	_
27	dividends	dividend	NNS	_	25	conj	_
28	or	or	CC	_	27	cc	_
29	other	other	JJ	_	30	amod	_
30	purposes	purpose	NNS	_	27	conj	_
31	--	--	:	_	16	punct	_
32	without	without	IN	_	16	prep	16:AM-MNR
33	paying	pay	VBG	pb=pay.01	32	pcomp	_
34	U.S.	u.s.	NNP	_	35	nn	_
35	tax	tax	NN	_	33	dobj	33:A1=VSP
36	on	on	IN	_	33	prep	33:AM-LOC
37	them	them	PRP	_	36	pobj	_
38	.	.	.	_	13	punct	_

1	While	while	IN	_	5	mark	_
2	its	its	PRP$	_	3	poss	_
3	headquarters	headquarters	NN	p2=NNS	5	nsubj	5:A1=PPT
4	would	would	MD	_	5	aux	5:AM-MOD
5	remain	remain	VB	pb=remain.01	17	advcl	17:AM-ADV
6	in	in	IN	_	5	prep	5:A3=PRD
7	New	new	NNP	_	8	nn	_
8	York	york	NNP	_	6	pobj	_
9	,	,	,	_	17	punct	_
10	a	a	DT	_	14	det	_
11	Pfizer	pfizer	NNP	_	13	hmod	_
12	-	-	HYPH	_	13	hyph	_
13	AstraZeneca	astrazeneca	NNP	_	14	nn	_
14	combination	combination	NN	_	17	nsubjpass	29:A0=PAG;17:A1
15	would	would	MD	_	17	aux	17:AM-MOD
16	be	be	VB	_	17	auxpass	_
17	domiciled	domicile	VBN	pb=domicile.01	0	root	_
18	for	for	IN	_	17	prep	17:A2
19	tax	tax	NN	_	20	nn	_
20	purposes	purpose	NNS	_	18	pobj	_
21	in	in	IN	_	20	prep	_
22	the	the	DT	_	25	det	_
23	U.K.	u.k.	NNP	_	25	nn	_
24	The	the	NNP	p2=DT	25	nn	_
25	U.K.	u.k.	NNP	_	21	pobj	_
26	has	have	VBZ	_	29	aux	_
27	been	be	VBN	_	29	aux	_
28	steadily	steadily	RB	_	29	advmod	29:AM-MNR
29	cutting	cut	VBG	pb=cut.02	17	advcl	17:AM-ADV
30	its	its	PRP$	_	31	poss	_
31	rate	rate	NN	_	29	dobj	29:A1=PPT
32	of	of	IN	_	31	prep	_
33	corporate	corporate	JJ	_	34	amod	_
34	tax	tax	NN	_	32	pobj	_
35	.	.	.	_	17	punct	_

1	It	it	PRP	_	3	nsubj	3:A1=PPT;8:A1=PPT
2	now	now	RB	_	3	advmod	3:AM-TMP;8:AM-TMP
3	stands	stand	VBZ	pb=stand.04	0	root	_
4	at	at	IN	_	3	prep	3:A2=PRD
5	21	0	CD	_	6	num	_
6	%	%	NN	_	4	pobj	_
7	and	and	CC	_	3	cc	_
8	is	be	VBZ	pb=be.01	3	conj	_
9	due	due	JJ	_	8	acomp	8:A2=PRD
10	to	to	TO	p2=IN	11	aux	_
11	fall	fall	VB	pb=fall.01	9	xcomp	_
12	to	to	IN	_	11	prep	11:A4=GOL
13	20	0	CD	_	14	num	_
14	%	%	NN	_	15	nn	_
15	starting	starting	NN	p2=VBG	12	pobj	_
16	in	in	IN	_	11	prep	11:AM-TMP
17	April	april	NNP	_	16	pobj	_
18	2015	0	CD	_	17	num	_
19	.	.	.	_	3	punct	_

1	That	that	DT	_	2	nsubj	2:A1=PPT
2	compares	compare	VBZ	pb=compare.01	0	root	_
3	with	with	IN	_	2	prep	2:A2=PPT
4	26	0	CD	_	5	num	_
5	%	%	NN	_	3	pobj	_
6	back	back	RB	p2=NN	5	advmod	_
7	in	in	IN	_	6	prep	_
8	2011	0	CD	_	7	pobj	_
9	.	.	.	_	2	punct	_

1	The	the	DT	_	2	det	_
2	government	government	NN	_	4	nsubj	4:A0=PAG;8:A0=PAG
3	also	also	RB	_	4	advmod	4:AM-DIS
4	offers	offer	VBZ	pb=offer.01	0	root	_
5	financial	financial	JJ	_	6	amod	_
6	incentives	incentive	NNS	_	4	dobj	4:A1=PPT
7	to	to	TO	_	8	aux	_
8	encourage	encourage	VB	pb=encourage.02	4	advcl	4:AM-PRP
9	investment	investment	NN	_	8	dobj	8:A1=PPT
10	in	in	IN	_	9	prep	_
11	scientific	scientific	JJ	_	12	amod	_
12	research	research	NN	_	10	pobj	_
13	and	and	CC	_	12	cc	_
14	development	development	NN	_	12	conj	_
15	.	.	.	_	4	punct	_

1	Big	big	JJ	_	2	amod	_
2	companies	company	NNS	_	6	nsubj	6:A1=PPT
3	such	such	JJ	_	4	amod	_
4	as	as	IN	_	2	prep	_
5	AstraZeneca	astrazeneca	NNP	p2=NNS	4	pobj	_
6	qualify	qualify	VBP	p2=VB|pb=qualify.02	0	root	_
7	for	for	IN	_	6	prep	6:A2=PRD
8	tax	tax	NN	_	9	nn	_
9	relief	relief	NN	_	7	pobj	_
10	worth	worth	JJ	p2=NN	9	amod	_
11	130	0	CD	_	12	num	_
12	%	%	NN	_	10	npadvmod	_
13	on	on	IN	_	6	prep	_
14	their	their	PRP$	_	16	poss	_
15	research	research	NN	_	16	nn	_
16	budgets	budget	NNS	_	13	pobj	_
17	.	.	.	_	6	punct	_

1	That	that	DT	_	2	nsubj	2:A0=PAG
2	means	mean	VBZ	p2=NNS|pb=mean.01	11	ccomp	_
3	for	for	IN	_	2	prep	2:A1=PPT
4	each	each	DT	_	5	det	_
5	£100	£0	NN	p2=NNS	3	pobj	7:A1=PPT
6	it	it	PRP	_	7	nsubj	7:A0=PAG
7	spends	spend	VBZ	pb=spend.01	5	rcmod	_
8	,	,	,	_	11	punct	_
9	it	it	PRP	_	11	nsubj	11:A0
10	can	can	MD	_	11	aux	11:AM-MOD
11	reduce	reduce	VB	pb=reduce.01	0	root	_
12	the	the	DT	_	13	det	_
13	amount	amount	NN	_	11	dobj	11:A1=PPT
14	of	of	IN	_	13	prep	_
15	profit	profit	NN	_	14	pobj	_
16	liable	liable	JJ	_	15	amod	_
17	to	to	IN	_	16	prep	_
18	corporate	corporate	JJ	_	19	amod	_
19	tax	tax	NN	_	17	pobj	_
20	by	by	IN	_	16	prep	_
21	£130	£0	NN	p2=NNS	20	pobj	_
22	.	.	.	_	11	punct	_

1	Companies	company	NNS	_	8	nsubj	8:A0;2:A1=PPT
2	involved	involve	VBN	p2=JJ|pb=involve.01	1	partmod	_
3	in	in	IN	_	2	prep	2:A2=PPT
4	innovative	innovative	JJ	_	5	amod	_
5	R&D	r&d	NN	p2=NNP	3	pobj	_
6	can	can	MD	_	8	aux	8:AM-MOD
7	also	also	RB	_	8	advmod	8:AM-DIS
8	take	take	VB	pb=take.01	0	root	_
9	advantage	advantage	NN	_	8	dobj	8:A1=PPT
10	of	of	IN	_	8	prep	8:A2=DIR
11	a	a	DT	_	13	det	_
12	new	new	JJ	_	13	amod	_
13	measure	measure	NN	_	10	pobj	14:A1=PPT
14	called	call	VBN	pb=call.01	13	partmod	_
15	"	"	``	_	18	punct	_
16	the	the	DT	_	18	det	_
17	patent	patent	NN	_	18	nn	_
18	box	box	NN	_	14	oprd	14:A2=PRD
19	.	.	.	_	8	punct	_
20	"	"	''	_	8	punct	_

1	Introduced	introduce	VBN	p2=VBD|pb=introduce.02	8	advcl	8:AM-ADV
2	in	in	IN	_	1	prep	1:AM-TMP
3	April	april	NNP	_	2	pobj	_
4	2013	0	CD	_	3	num	_
5	,	,	,	_	8	punct	_
6	it	it	PRP	_	8	nsubj	8:A0
7	will	will	MD	_	8	aux	8:AM-MOD
8	reduce	reduce	VB	pb=reduce.01	0	root	_
9	the	the	DT	_	12	det	_
10	corporate	corporate	JJ	_	12	amod	_
11	tax	tax	NN	_	12	nn	_
12	rate	rate	NN	_	8	dobj	8:A1=PPT
13	on	on	IN	_	12	prep	_
14	earnings	earnings	NNS	_	13	pobj	_
15	attributable	attributable	JJ	_	14	amod	_
16	to	to	IN	_	15	prep	_
17	U.K.	u.k.	NNP	_	16	pobj	_
18	or	or	CC	_	17	cc	_
19	European	european	JJ	p2=NNP	20	amod	_
20	patents	patent	NNS	_	17	conj	_
21	to	to	IN	p2=TO	15	prep	_
22	10	0	CD	_	23	num	_
23	%	%	NN	p2=NNS	21	pobj	_
24	by	by	IN	_	15	prep	_
25	2017	0	CD	_	24	pobj	_
26	.	.	.	_	8	punct	_

1	Pressure	pressure	NN	_	4	nsubj	4:A1=PPT
2	had	have	VBD	_	4	aux	_
3	been	be	VBN	_	4	aux	_
4	mounting	mount	VBG	pb=mount.02	0	root	_
5	on	on	IN	_	4	prep	4:AM-LOC
6	the	the	DT	_	8	det	_
7	British	british	JJ	_	8	amod	_
8	government	government	NN	_	5	pobj	_
9	to	to	TO	_	10	aux	_
10	intervene	intervene	VB	pb=intervene.01	4	advcl	_
11	in	in	IN	_	10	prep	10:A1=PPT
12	the	the	DT	_	13	det	_
13	deal	deal	NN	_	11	pobj	_
14	.	.	.	_	4	punct	_

1	Pharmaceutical	pharmaceutical	JJ	p2=NNP	8	nn	_
2	,	,	,	_	1	punct	_
3	medical	medical	JJ	_	4	amod	_
4	biotechnology	biotechnology	NN	_	1	conj	_
5	and	and	CC	_	4	cc	_
6	medical	medical	JJ	_	7	amod	_
7	technology	technology	NN	_	4	conj	_
8	companies	company	NNS	_	9	nsubj	9:A0=PAG;15:A0=PAG
9	employ	employ	VBP	pb=employ.01	0	root	_
10	about	about	RB	p2=IN	11	advmod	_
11	175,000	0	CD	_	12	num	_
12	people	people	NNS	_	9	dobj	9:A1=PPT
13	,	,	,	_	9	punct	_
14	and	and	CC	_	9	cc	_
15	spend	spend	VB	p2=VBP|pb=spend.01	9	conj	_
16	more	more	JJR	_	19	amod	_
17	than	than	IN	_	19	quantmod	_
18	£5	£0	CD	p2=NNS	19	number	_
19	billion	#crd#	CD	_	15	dobj	15:A3=VSP
20	a	a	DT	_	21	det	_
21	year	year	NN	_	19	npadvmod	_
22	on	on	IN	_	15	prep	15:A1=PPT
23	R&D	r&d	NN	p2=NNP	22	pobj	_
24	.	.	.	_	9	punct	_

1	Concerns	concern	NNS	p2=VBZ	13	nsubjpass	13:A1=GOL
2	about	about	IN	_	1	prep	_
3	pledges	pledge	NNS	_	2	pobj	4:AM-PRR
4	made	make	VBN	pb=make.05	3	partmod	_
5	in	in	IN	_	4	prep	4:AM-LOC
6	the	the	DT	_	7	det	_
7	heat	heat	NN	_	5	pobj	_
8	of	of	IN	_	7	prep	_
9	takeover	takeover	NN	_	10	nn	_
10	battles	battle	NNS	_	8	pobj	_
11	have	have	VBP	_	13	aux	_
12	been	be	VBN	_	13	auxpass	_
13	fueled	fuel	VBN	pb=fuel.01	0	root	_
14	by	by	IN	_	13	agent	13:A2=PPT
15	complaints	complaint	NNS	_	14	pobj	_
16	that	that	IN	p2=WDT	18	complm	_
17	Pfizer	pfizer	NNP	_	18	nsubj	20:A0=PAG;18:A1=PAG
18	failed	fail	VBD	pb=fail.01	15	ccomp	_
19	to	to	TO	_	20	aux	_
20	honor	honor	VB	pb=honor.01	18	xcomp	18:A2=PPT
21	pledges	pledge	NNS	_	20	dobj	20:A1=PPT
22	to	to	IN	_	20	prep	20:A2=CAU
23	Sweden	sweden	NNP	_	25	poss	_
24	's	's	POS	_	23	possessive	_
25	Pharmacia	pharmacia	NNP	p2=NN	22	pobj	_
26	in	in	IN	_	20	prep	20:AM-TMP
27	2002	0	CD	_	26	pobj	_
28	,	,	,	_	13	punct	_
29	and	and	CC	_	13	cc	_
30	Kraft	kraft	NNP	_	32	poss	_
31	's	's	POS	p2=VBZ	30	possessive	_
32	U-turn	u-turn	NN	p2=JJ	13	npadvmod	_
33	on	on	IN	_	32	prep	_
34	the	the	DT	_	35	det	_
35	fate	fate	NN	_	33	pobj	_
36	of	of	IN	_	35	prep	_
37	a	a	DT	_	39	det	_
38	chocolate	chocolate	NN	_	39	nn	_
39	factory	factory	NN	_	36	pobj	40:A0=PAG
40	following	follow	VBG	pb=follow.01	39	partmod	_
41	its	its	PRP$	_	42	poss	_
42	purchase	purchase	NN	_	40	dobj	40:A1=PPT
43	of	of	IN	_	42	prep	_
44	Cadbury	cadbury	NNP	_	43	pobj	_
45	in	in	IN	_	42	prep	_
46	2010	0	CD	_	45	pobj	_
47	.	.	.	_	13	punct	_

1	--	--	:	_	4	punct	_
2	Mark	mark	NNP	_	3	nn	_
3	Thompson	thompson	NNP	_	4	nsubj	4:A0=PAG
4	contributed	contribute	VBD	pb=contribute.01	0	root	_
5	reporting	report	VBG	p2=NN	4	dobj	4:A1=PPT
6	.	.	.	_	4	punct	_

1	Market	market	NN	p2=NNP	2	nn	_
2	indexes	index	NNS	_	4	nsubjpass	4:A1=PPT
3	are	be	VBP	_	4	auxpass	_
4	shown	show	VBN	pb=show.01	0	root	_
5	in	in	IN	_	4	prep	4:AM-TMP
6	real	real	JJ	_	7	amod	_
7	time	time	NN	_	5	pobj	_
8	,	,	,	_	4	punct	_
9	except	except	IN	_	4	prep	4:AM-ADV
10	for	for	IN	_	9	prep	_
11	the	the	DT	_	12	det	_
12	DJIA	djia	NNP	_	10	pobj	16:A1=PPT
13	,	,	,	_	12	punct	_
14	which	which	WDT	_	16	nsubjpass	16:R-A1
15	is	be	VBZ	_	16	auxpass	_
16	delayed	delay	VBN	pb=delay.01	12	rcmod	_
17	by	by	IN	_	16	agent	16:A0=PAG
18	two	#crd#	CD	_	19	num	_
19	minutes	minute	NNS	_	17	pobj	_
20	.	.	.	_	4	punct	_

1	All	all	DT	_	2	det	_
2	times	time	NNS	_	3	nsubj	3:A1=PPT
3	are	be	VBP	pb=be.01	0	root	_
4	ET	et	NNP	p2=JJ	3	attr	3:A2=PRD
5	.	.	.	_	3	punct	_

1	Disclaimer	disclaimer	NN	p2=VB	2	nn	_
2	Morningstar	morningstar	NN	p2=NNP	0	root	_
3	:	:	:	_	2	punct	_
4	©	©	$	p2=IN	5	nmod	_
5	2014	0	CD	_	8	nn	_
6	Morningstar	morningstar	NNP	p2=NN	8	nn	_
7	,	,	,	_	8	punct	_
8	Inc	inc	NNP	_	2	appos	_
9	.	.	.	_	2	punct	_

1	All	all	DT	p2=PDT	3	det	_
2	Rights	right	NNPS	p2=NNS	3	nn	3:A0
3	Reserved	reserved	VBD	p2=VBD|pb=reserve.01	0	root	_
4	.	.	.	_	3	punct	_

1	Disclaimer	disclaimer	NN	p2=NNP	6	npadvmod	6:AM-TMP
2	The	the	DT	p2=NNP	5	det	_
3	Dow	dow	NNP	_	4	nn	_
4	Jones	jones	NNP	_	5	nn	_
5	IndexesSM	indexessm	NNP	p2=NNPS	6	nsubj	6:A1=PPT;10:A1=PPT
6	are	be	VBP	pb=be.01	0	root	_
7	proprietary	proprietary	JJ	_	6	acomp	6:A2=PRD
8	to	to	IN	_	7	prep	_
9	and	and	CC	_	7	cc	_
10	distributed	distribute	VBN	pb=distribute.01	7	conj	_
11	by	by	IN	_	10	agent	10:A0=PAG
12	Dow	dow	NNP	_	13	nn	_
13	Jones	jones	NNP	_	17	nn	_
14	&	&	CC	_	13	cc	_
15	Company	company	NNP	_	13	conj	_
16	,	,	,	_	17	punct	_
17	Inc	inc	NNP	_	11	pobj	_
18	.	.	.	_	6	punct	_

1	and	and	CC	_	4	cc	4:AM-DIS
2	have	have	VBP	p2=VB	4	aux	_
3	been	be	VBN	_	4	auxpass	_
4	licensed	license	VBN	p2=JJ|pb=license.01	0	root	_
5	for	for	IN	_	4	prep	4:A2=GOL
6	use	use	NN	_	5	pobj	_
7	.	.	.	_	4	punct	_

1	All	all	DT	_	2	det	_
2	content	content	NN	_	10	nsubj	10:A1=PPT
3	of	of	IN	_	2	prep	_
4	the	the	DT	_	8	det	_
5	Dow	dow	NNP	_	6	nn	_
6	Jones	jones	NNP	_	8	nn	_
7	IndexesSM	indexessm	NNP	_	8	nn	_
8	©	©	NNP	p2=POS	3	pobj	_
9	2014	0	CD	_	8	num	_
10	is	be	VBZ	pb=be.01	0	root	_
11	proprietary	proprietary	JJ	_	10	acomp	10:A2=PRD
12	to	to	IN	_	11	prep	_
13	Dow	dow	NNP	_	14	nn	_
14	Jones	jones	NNP	_	18	nn	_
15	&	&	CC	_	14	cc	_
16	Company	company	NNP	_	14	conj	_
17	,	,	,	_	18	punct	_
18	Inc	inc	NNP	_	12	pobj	_
19	.	.	.	_	10	punct	_

1	Chicago	chicago	NNP	_	3	nn	_
2	Mercantile	mercantile	NNP	_	3	nn	_
3	Association	association	NNP	_	0	root	_
4	.	.	.	_	3	punct	_

1	The	the	DT	_	3	det	_
2	market	market	NN	_	3	nn	_
3	data	data	NN	p2=NNS	4	nsubj	4:A1=PPT
4	is	be	VBZ	pb=be.01	0	root	_
5	the	the	DT	_	6	det	_
6	property	property	NN	_	4	attr	4:A2=PRD
7	of	of	IN	_	6	prep	_
8	Chicago	chicago	NNP	_	11	nn	_
9	Mercantile	mercantile	NNP	_	11	nn	_
10	Exchange	exchange	NNP	_	11	nn	_
11	Inc	inc	NNP	_	7	pobj	_
12	.	.	.	_	4	punct	_

1	and	and	CC	_	3	cc	_
2	its	its	PRP$	_	3	poss	_
3	licensors	licensors	NNS	_	0	root	_
4	.	.	.	_	3	punct	_

1	All	all	DT	_	2	det	_
2	rights	right	NNS	_	3	nsubj	3:A1=PPT
3	reserved	reserve	VBN	p2=VBD|pb=reserve.01	0	root	_
4	.	.	.	_	3	punct	_

1	FactSet	factset	NNP	_	4	nn	_
2	Research	research	NNP	_	4	nn	_
3	Systems	system	NNPS	p2=NNP	4	nn	_
4	Inc	inc	NNP	_	0	root	_
5	.	.	.	_	4	punct	_

1	2014	0	CD	p2=LS	0	root	_
2	.	.	.	_	1	punct	_

1	All	all	DT	_	2	det	_
2	rights	right	NNS	_	3	nsubj	3:A1=PPT
3	reserved	reserve	VBN	p2=VBD|pb=reserve.01	0	root	_
4	.	.	.	_	3	punct	_

1	Most	most	JJS	_	4	amod	_
2	stock	stock	NN	_	3	nn	_
3	quote	quote	NN	p2=UH	4	nn	_
4	data	datum	NNS	p2=NN	0	root	5:A1
5	provided	provided	VBN	pb=provide.01	4	partmod	_
6	by	by	IN	_	5	agent	5:A0
7	BATS	bat	NNS	p2=NNP	6	pobj	_
8	.	.	.	_	4	punct	_

